Gross Profit On Sales Изменить Дата
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Akebia Therapeutics USD 45.68M 13.5M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
Amgen USD 5.08B 14M 2023-12
Baxter International USD 1.49B 351M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Fujifilm JPY 295.21B 32.04B 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
Merck USD 11.29B 441M 2023-12
Myriad Genetics USD 135M 700K 2023-12
Pacira USD 133.55M 9.38M 2023-12
Perrigo USD 411.2M 16.8M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Revance Therapeutics USD 37.36M 536K 2023-09
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09
Zoetis USD 1.49B 27M 2023-12



Coherus Biosciences Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.